Antolin J, Amerigo M J, Cantabrana A, Roces A, Jimenez P
Internal Medicine Service Ntra.Sra.de La Candelaria Hospital, Tenerife, Spain.
Clin Rheumatol. 1995 Nov;14(6):678-85. doi: 10.1007/BF02207936.
We analysed the prevalence of clinical manifestations and immunological parameters in 194 patients with SLE and classified them in subgroups according to age at onset, gender and type of antibodies: we detected significant differences in the various subgroups. In SLE that initiated before the age of 20 years, the most frequent manifestation at onset was malar rash (25% vs 14%). During the course of the disease, this group had a greater prevalence of malar rash (70% vs 45%), mouth ulcers (48% vs 29%), and convulsions or psychosis (35% vs. 17%). In SLE that initiated late in life (after 50 years) malar rash was less frequent at onset and during subsequent evolution of the disease (27% vs 45%). The existence of ANA, and elevated values of anti-dsDNA, anti-ENA and antiphospholipid antibodies also differentiated the SLE subgroups with clinical significance.
我们分析了194例系统性红斑狼疮(SLE)患者的临床表现和免疫参数,并根据发病年龄、性别和抗体类型将他们分为不同亚组:我们在各亚组中检测到显著差异。在20岁之前发病的SLE患者中,发病时最常见的表现是颧部红斑(25% 对14%)。在疾病过程中,该组颧部红斑(70% 对45%)、口腔溃疡(48% 对29%)以及惊厥或精神病(35% 对17%)的发生率更高。在晚年(50岁以后)发病的SLE患者中,发病时及疾病后续进展过程中颧部红斑的发生率较低(27% 对45%)。抗核抗体(ANA)的存在以及抗双链DNA(anti-dsDNA)、抗可提取核抗原(anti-ENA)和抗磷脂抗体水平的升高也在具有临床意义的SLE亚组之间存在差异。